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On page 1086, [Table 1](#t1-cia-11-1815){ref-type="table"} should be replaced by the following table:

On page 1087, [Table 2](#t2-cia-11-1815){ref-type="table"} should be replaced by the following table:

###### 

Age distribution and medical history in the older outpatient study population

                                             Total, n (%)   Males, n (%)   Females, n (%)   *P*-value for sex differences
  ------------------------------------------ -------------- -------------- ---------------- -------------------------------
  Sex                                        200 (100)      88 (44.0)      112 (56.0)       n.s
                                                                                            
  **Age cohorts (years)**                                                                   
  66--80                                     125 (62.5)     51 (57.9)      74 (66.1)        0.040
  \>80                                       75 (37.5)      37 (42.1)      38 (33.9)        n.s
                                                                                            
  Heart failure                              11 (5.5)       3 (3.4)        8 (7.1)          n.s
  Hypertension                               99 (49.5)      46 (52.3)      53 (47.3)        n.s
  Diabetes                                   9 (4.5)        4 (4.5)        5 (4.4)          n.s
  Stroke                                     13 (6.5)       6 (6.8)        7 (6.2)          n.s
  Ischemic cardiac disease                   20 (10)        11 (12.5)      9 (8.0)          n.s
  Hyper/hypothyroidism                       20 (10)        3 (3.4)        17 (15.1)        n.s
  Smoking                                    10 (5)         5 (5.6)        5 (4.4)          n.s
  Medical treatment (eg, ASA and Warfarin)   17 (8.5)       11 (12.5)      6 (5.3)          n.s

**Abbreviations:** ASA, acetylsalicylic acid; n.s, not significant.

###### 

Heart rhythm and prevalence of arrhythmia during the analysis period in the study population

                                                                          Total (n=200), n (%)   95% CI for total sample   Males (n=88), n (%)   Females (n=112), n (%)   *P*-value for sex differences
  ----------------------------------------------------------------------- ---------------------- ------------------------- --------------------- ------------------------ -------------------------------
  Sinus rhythm                                                            165 (82.5)             77.23--87.77              75 (85.2)             90 (80.4)                n.s
  Persistent AF                                                           20 (10)                5.84--14.16               6 (6.9)               14 (12.5)                n.s
  Unspecified rhythm                                                      1 (0.5)                0.0--1.48                 1 (1.1)               0 (0)                    --
  Pacemaker rhythm                                                        3 (1.5)                0.0--3.18                 2 (2.3)               1 (0.9)                  --
  Paroxysmal AF                                                           11 (5.5)               2.34--8.66                4 (4.5)               7 (6.2)                  --
  Episodes of Paroxysmal supraventricular tachycardia (\>100 beats/min)   87 (43.5)              36.83--50.37              33 (37.5)             54 (48.2)                0.012

**Abbreviations:** AF, atrial fibrillation; CI, confidence interval; n.s, not significant.
